Technological platform

Vito Disgnostics has two medical laboratories in Hangzhou and Beijing, 100,000 level clean workshop, clinical mass spectrometry platform, biomedical research center / animal center, genome analysis and computing Center, and clinical medical research Center
Equipped with cutting-edge mass spectrometers, including Liquid Chromatography Tandem-mass Spectrometry (LC-MS / MS), Gas Chromatography-mass Spectrometry (GC-MS), UltraPerformance Liquid Chromatography (UHPLC), Inductively Coupled Plasma - Mass Spectrometry (ICP-MS), etc
The business focuses on common small molecular metabolites and biological macro-molecules in clinical biochemistry tests, which can meet the diversified detection needs of customers
The company put emphasis on translational medicine. Committed on the development and discovery of new biomarkers for the daily management of chronic diseases and the biological mechanism research. With the animal disease model and human biobank, bases on the quantitative detection of blood indicators and genome data analysis to create a new solution of integrated diagnosis and treatment oriented by specific diseases. At present, the main research projects include prenatal genetic diagnosis of congenital heart disease, risk monitoring of recurrent miscarriage, risk monitoring of cardiovascular and cerebrovascular diseases, and risk monitoring and treatment of heart failure

Core products

Relying on the strength of Westlake University's scientific research platform and industry experts, the company is committed to developing testing products with independent intellectual property rights and fit the real application scenarios of clinical diagnosis
At present, the key products include complete folate-function test (CFT), complete homocysteine-function test (CHT) and complete niacin-function test (CNT). This series of products have been introduced to the market and have been widely recognized by clinicians

Core team members

The operating members of the company come from the first-class enterprises, and have extensive experience in market operation in the clinic diagnosis field
The research team led by top experts at domestic and abroad. 40% of the team members have master's degrees or above, including 9 PhDs
The company promotes the development of scientific research with the support of the market, stakes the market operation with the scientific research synchronously. The company will realizing the elitization, toplization and specialization goals with the expanding and optimizing of the organizational structure and management